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Significance & InnovationsIn a representative population‐based sample, one quarter of respondents had joint symptoms typical of osteoarthritis (OA) but did not report an OA diagnosis.Other than being slightly younger, those reporting two or more joints as symptomatic were nearly indistinguishable from those reporting an OA diagnosis with respect to personal characteristics and outcome profiles.It may be warranted to consider OA‐like multiple joint symptoms when deriving estimates of OA‐attributed population health and cost burden.

Introduction {#acr211120-sec-0006}
============

Osteoarthritis (OA) is among the leading contributors to pain and disability globally [1](#acr211120-bib-0001){ref-type="ref"}, [2](#acr211120-bib-0002){ref-type="ref"}. It is also a key driver of health care utilization and lost productivity. A systematic review estimated the cost of OA to be between 0.25% and 0.50% of the Gross Domestic Product in industrialized nations [3](#acr211120-bib-0003){ref-type="ref"}. With the aging of the population, the clinical and economic burden of OA is expected to increase substantially [4](#acr211120-bib-0004){ref-type="ref"}, [5](#acr211120-bib-0005){ref-type="ref"}, [6](#acr211120-bib-0006){ref-type="ref"}.

From a health and policy planning perspective, understanding the number of individuals who have OA or may be at an elevated risk for OA is essential. The majority of published estimates of OA burden are based on an OA diagnosis whether determined from administrative health data or population‐based health surveys that specifically ask about "doctor‐diagnosed" OA [1](#acr211120-bib-0001){ref-type="ref"}, [7](#acr211120-bib-0007){ref-type="ref"}. By their very nature, these data are limited by their dependence on individuals visiting a physician. Individuals with arthritis often do not visit a physician until symptoms are moderate to severe [8](#acr211120-bib-0008){ref-type="ref"}, [9](#acr211120-bib-0009){ref-type="ref"}, [10](#acr211120-bib-0010){ref-type="ref"}; therefore, those with disease with milder symptoms may not be captured in administrative health or survey data. The consequence is that individuals without diagnosed OA but with OA joint symptoms and the resulting negative life and health impacts are missed. For assessing health and economic burden and for planning, these individuals matter as they also can contribute to costs through use of over‐the‐counter medications, aids, assistive devices, and lost productivity. Furthermore, OA joint symptoms, such as pain and disability, may act as barriers to the uptake of broader clinical and public health recommendations for individuals to be physically active and to maintain mobility.

Although some studies have reported on the overall prevalence of arthritis‐like joint symptoms without an arthritis diagnosis in the population [11](#acr211120-bib-0011){ref-type="ref"}, [12](#acr211120-bib-0012){ref-type="ref"}, [13](#acr211120-bib-0013){ref-type="ref"}, there has been limited study of these individuals. In this study, we take advantage of data from a large population‐based longitudinal study that elicited information on both OA diagnosis and joint symptoms indicative of OA. Our objectives were to compare individuals with an OA diagnosis to those with OA joint symptoms but without a diagnosis considering a number of sociodemographic and health characteristics, and additionally to assess the extent to which having OA and joint symptoms are associated with overall pain and functional limitations. Additionally, we subdivided individuals with joint symptoms into those with symptoms in one joint site and those with symptoms in multiple joint sites. This is an important distinction as it has been reported that there may be underlying and/or health outcome differences between individuals with and without multiple symptomatic joint involvement [14](#acr211120-bib-0014){ref-type="ref"}, [15](#acr211120-bib-0015){ref-type="ref"}.

Materials and Methods {#acr211120-sec-0007}
=====================

Data are from the Canadian Longitudinal Study on Aging (CLSA) [16](#acr211120-bib-0016){ref-type="ref"}. The CLSA is a study that collects medical, psychological, and sociodemographic information from men and women aged 45 to 85 years (at baseline) residing in Canada. The CLSA began in 2011 and will follow respondents for 20 years or until death. The first cycle of data (collected between 2013 and 2015) from the comprehensive sample was the basis for the present study, and analysis was restricted to those with complete data on study variables (n = 23 186). The comprehensive sample of the CLSA included a representative sample of respondents who resided within 25 to 50 km of one of the following 11 major centers across Canada: Vancouver, Victoria, Surrey, Calgary, Winnipeg, Hamilton, Ottawa, Montreal, Sherbrooke, Halifax, and St. John\'s.

Respondents were asked whether a doctor had ever told them they have OA in the knee, in the hip, or in the hand. Those responding in the affirmative to any of these were categorized as having OA. Respondents were asked about the presence of typical OA symptoms over the previous 4 weeks in the knees: knee pain on most days, knee pain while climbing stairs or walking down slopes, and swelling in the knee. Respondents were also asked about typical OA symptoms over the previous 4 weeks in the hips: pain in the groin or upper inner thigh on most days, and pain in the groin or upper inner thigh when climbing stairs or walking down slopes. Finally, respondents were also asked about typical OA symptoms over the previous 4 weeks in the hands: enlargement of small joints close to the fingernails, pain on most days in the small joints close to the fingernails, enlargement in the base of the thumbs, and pain on most days in the base of the thumbs. Those providing a positive response to any of the joint symptom questions but who provided a negative response to the OA diagnosis questions were categorized as having joint symptoms indicative of OA (labeled "possible OA"). For greater granularity, the possible OA group was subdivided into two groups based on the extent of joint symptoms. From the totality of these questions, all respondents were placed into one of four mutually exclusive categories: diagnosed OA, possible OA in one joint site (possible OA1), possible OA in more than one joint site (possible OA2), and no OA or joint symptoms (Nn).

A number of sociodemographic and health‐related characteristics were included in the study. For analysis, age was categorized as 45 to 54, 55 to 64, 65 to 74, and 75 to 85 years. Body mass index (BMI) was calculated using measured height and weight and operationalized as "normal" (BMI below 25), "overweight" (BMI between 25 and 29.99), and "obese" (BMI of 30 or more). Education level was dichotomized as "post‐secondary" and "high school or less," and a four‐level annual household income variable was derived (in Canadian dollars: \$50 000 or less, \$50 000 to \$99 999, \$100 000 to \$149 999, and \$150 000 or more). Respondents were asked about the presence of co‐occurring conditions (cancer, cardiovascular, neurological, gastrointestinal, respiratory, ocular, mental, and endocrine). The number of positive responses was summed, and the number of co‐occurring conditions was categorized as 0, 1 to 2, and 3 or more [17](#acr211120-bib-0017){ref-type="ref"}.

Respondents were asked generally if they usually experienced pain or discomfort (yes/no). Functional limitations were assessed by asking respondents whether they could perform the following 14 Activities of Daily Living (ADLs) without help: dressing, feeding, taking care of one\'s appearance, walking, getting out of bed, bathing, using the telephone, traveling, shopping, preparing meals, doing housework, taking medicine, handling money, and getting to the bathroom on time. Individuals were categorized (yes/no) as needing help if they were unable to perform at least one of these activities without help.

Descriptive statistics were calculated for the overall sample and by OA status (ie, diagnosed OA, possible OA1, possible OA2, and Nn). A multinomial logistic regression model examined the relationship between sociodemographic and health‐related characteristics and OA status (model outcome: diagnosed OA/possible OA1/possible OA2/Nn \[referent group\]). Two subsequent logistic regression models assessed the relationship between OA status and usually experiencing pain (outcome: yes/no) and having some degree of functional limitation (outcome: yes/no). These two models were adjusted for the sociodemographic and health characteristics.

Sampling weights provided by the CLSA were used to produce descriptive statistics. All analyses were performed in SAS version 9.4.

Results {#acr211120-sec-0008}
=======

Characteristics of the sample, overall and by OA status, are presented in Table [1](#acr211120-tbl-0001){ref-type="table"}. Just over 21% of respondents reported a diagnosis of OA, and 21% and 4.5% were categorized as having possible OA1 and possible OA2, respectively. Compared with the possible OA1 group, the possible OA2 group was more likely to be female and older, to have a lower household income, to be obese, to have three or more co‐occurring conditions, and to be more likely to report usually experiencing pain and having difficulty with at least one ADL. There was minimal difference between the diagnosed OA and possible OA2 groups, other than the diagnosed OA group being somewhat older. A description of the frequency of typical OA symptoms at each joint site by group is provided in [Table S1](#acr211120-sup-0001){ref-type="supplementary-material"}.

###### 

Characteristics of respondents from the Canadian Longitudinal Study on Aging: comprehensive sample, overall, and by OA status[a](#acr211120-note-0005){ref-type="fn"}

   Characteristics          Overall   Diagnosed OA   Possible OA2   Possible OA1   Nn
  ------------------------- --------- -------------- -------------- -------------- --------
  Sample size               23 186    5865           1157           4921           11 243
  \% of sample              100       21.2           4.5            21.0           53.3
  Sex                                                                               
  Female                    49.0      59.8           65.0           51.5           42.3
  Age (y)                                                                           
  45‐54                     44.6      24.3           37.7           43.8           53.6
  55‐64                     30.7      34.5           32.5           32.6           28.4
  65‐74                     15.9      25.4           20.1           14.9           12.2
  75‐85                     8.7       15.8           9.7            8.7            5.8
  Household income                                                                  
  \$150 000+                22.8      16.1           18.1           20.2           26.9
  \$100 000‐\$149 999       23.5      19.4           18.8           24.8           25.1
  \$50 000‐\$99 999         34.1      38.5           37.9           34.6           31.8
  \<\$50 000                19.6      25.0           25.2           20.4           16.2
  Education                                                                         
  Postsecondary             81.3      78.2           77.8           80.7           83.1
  Body mass index                                                                   
  Normal                    33.1      26.1           28.1           30.8           37.2
  Overweight                40.3      37.2           37.6           42.0           41.2
  Obese                     26.6      36.7           34.3           27.2           21.6
  Co‐occurring conditions                                                           
  0                         22.2      11.5           10.8           20.7           27.9
  1‐2                       50.5      43.5           42.5           51.9           53.4
  3+                        27.3      45.0           46.7           27.4           18.7
  Usual pain                                                                        
  Yes                       34.4      55.5           55.2           37.2           23.1
  Difficulty with ≥1 ADL                                                            
  Yes                       12.9      23.1           19.3           12.0           8.6

Abbreviation: ADL, Activities of Daily Living; Nn, no osteoarthritis and no symptoms; OA, osteoarthritis; Possible OA1, no OA diagnosis but symptoms in one joint site; Possible OA2, no OA diagnosis but symptoms in two or more joint sites.

All proportions were calculated using sampling weights provided by the Canadian Longitudinal Study on Aging.

John Wiley & Sons, Ltd

Results from the single multinomial logistic regression analysis examining adjusted associations between sociodemographic and health characteristics and OA status are presented in Table [2](#acr211120-tbl-0002){ref-type="table"} (four‐category outcome: ref = Nn). The same set of factors associated with a significantly higher likelihood of reporting diagnosed OA were also associated with a significantly higher likelihood of both possible OA designations. These factors were older age, female sex, being overweight or obese, having a greater number of co‐occurring conditions, and lower household income. Other than for increasing age, where associations were greatest for diagnosed OA, the magnitudes of associations were statistically similar between those with diagnosed OA and those with possible OA2 ([Table S2](#acr211120-sup-0001){ref-type="supplementary-material"}). Comparatively, magnitudes of associations were lower for possible OA1.

###### 

Results from multinomial logistic regression model (four‐category outcome: OA, OA2, OA1, Nn)

   Model Variables                                    Model Outcome Categories                      
  --------------------------------------------------- -------------------------- ------------------ ------------------
  Age (vs. 45‐54)                                                                                    
  55‐64                                               2.45 (2.22‐2.70)           1.46 (1.24‐1.72)   1.39 (1.28‐1.51)
  65‐74                                               3.69 (3.31‐4.10)           1.72 (1.43‐2.07)   1.41 (1.27‐1.56)
  75‐85                                               4.66 (4.13‐5.27)           1.77 (1.42‐2.19)   1.69 (1.50‐1.90)
  Sex (female vs. male)                               2.27 (2.11‐2.43)           2.64 (2.31‐3.01)   1.58 (1.47‐1.69)
  BMI (vs. normal)                                                                                   
  Overweight                                          1.31 (1.21‐1.42)           1.39 (1.19‐1.62)   1.24 (1.14‐1.34)
  Obese                                               2.22 (2.03‐2.42)           2.02 (1.73‐2.37)   1.42 (1.30‐1.56)
  Comorbidities (vs. none)                                                                           
  1‐2                                                 1.49 (1.34‐1.66)           1.54 (1.24‐1.91)   1.20 (1.09‐1.32)
  3+                                                  2.88 (2.58‐3.21)           3.17 (2.56‐3.93)   1.55 (1.40‐1.71)
  Education (high school or less vs. postsecondary)   0.96 (0.88‐1.04)           1.08 (0.93‐1.25)   1.05 (0.96‐1.21)
  Income (vs. \$150 000+)                                                                            
  \$100 000‐\$149 999                                 1.08 (0.96‐1.21)           1.15 (0.93‐1.43)   1.10 (0.99‐1.22)
  \$50 000‐\$99 999                                   1.19 (1.07‐1.32)           1.29 (1.06‐1.57)   1.12 (1.01‐1.24)
  \<\$50 000                                          1.20 (1.07‐1.34)           1.38 (1.11‐1.70)   1.17 (1.04‐1.31)

Abbreviation: BMI, body mass index; CI, confidence interval; Nn, no osteoarthritis and no symptoms; OA, osteoarthritis; Possible OA1, no OA diagnosis but symptoms in one joint site; Possible OA2, no OA diagnosis but symptoms in two or more joint sites.

John Wiley & Sons, Ltd

Results from the logistic regression models examining usual pain and functional limitations and their association with OA status are presented in Table [3](#acr211120-tbl-0003){ref-type="table"}. Adjusted for age, sex, BMI, number of co‐occurring conditions, level of education and household income, individuals in the diagnosed OA group and possible OA2 group were equally likely to report experiencing pain and functional limitations compared with the Nn group (odds ratio for usual pain, diagnosed OA vs. possible OA2: 1.07 \[0.94, 1.23\]; odds ratio for needing help with one or more ADL, diagnosed OA vs. possible OA2: 1.13 \[0.96, 1.33\]). The possible OA1 group was also more likely to report usually experiencing pain but comparatively to a lesser degree.

###### 

Results from the two logistic regression analyses

   Model Variables                       Outcome: Usually Experience Pain vs. Not   Outcome: Needing Help with ≥1 ADL vs. Not
  -------------------------------------- ------------------------------------------ -------------------------------------------
  OA status (ref = Nn)                                                               
  Possible OA1                           1.76 (1.63‐1.90)                           1.05 (0.94‐1.17)
  Possible OA2                           3.07 (2.70‐3.50)                           1.25 (1.06‐1.47)
  Diagnosed OA                           3.30 (3.07‐3.56)                           1.41 (1.28‐1.55)
  Age                                                                                
  Age in years                           0.98 (0.97‐0.98)                           1.03 (1.03‐1.04)
  Sex (ref = male)                                                                   
  Female                                 1.04 (0.97‐1.10)                           2.19 (2.01‐2.38)
  BMI (ref = normal)                                                                 
  Overweight                             1.13 (1.05‐1.21)                           1.13 (1.02‐1.25)
  Obese                                  1.48 (1.37‐1.60)                           1.73 (1.57‐1.92)
  Co‐occurring conditions (continuous)                                               
  Number of conditions                   1.31 (1.29‐1.34)                           1.31 (1.28‐1.34)
  Education (ref = postsecondary)                                                    
  High school or less                    1.13 (1.05‐1.21)                           1.11 (1.01‐1.22)
  Household income (ref = ≥\$150 000)                                                
  \$100 000‐\$149 999                    1.19 (1.08‐1.31)                           1.27 (1.09‐1.48)
  \$50 000‐\$99 999                      1.32 (1.21‐1.44)                           1.43 (1.25‐1.65)
  \<\$50 000                             1.77 (1.61‐1.96)                           1.92 (1.66‐2.22)

Abbreviation: ADL, Activities of Daily Living; BMI, body mass index; Nn, no osteoarthritis and no symptoms; OA, osteoarthritis; Possible OA1, no OA diagnosis but symptoms in one joint site; Possible OA2, no OA diagnosis but symptoms in two or more joint sites.

John Wiley & Sons, Ltd

Discussion {#acr211120-sec-0009}
==========

In this large population‐based study, we found that one quarter of respondents reported symptoms indicative of OA but without an OA diagnosis. Unlike most previous work in this area, a distinction was made between individuals with symptoms in a single joint site versus those with symptoms in multiple joint sites, and we report strong similarities in the personal characteristics and outcomes between those with symptoms in multiple sites (but without an OA diagnosis) and those reporting an OA diagnosis.

The prevalence estimates of joint symptoms without a diagnosis that we report are consistent with those reported by others. In a population‐based US sample aged 45 years or older, Feinglass et al reported a "possible arthritis" (ie, having arthritis‐like joint symptoms but without diagnosed arthritis) prevalence of 22% [11](#acr211120-bib-0011){ref-type="ref"}, as was found in a Canadian‐based study [12](#acr211120-bib-0012){ref-type="ref"}. Busija et al reported a joint symptom (pain, aching, stiffness, or swelling in or around a joint excluding the back or neck) prevalence of 24% from a population‐based Australian sample [13](#acr211120-bib-0013){ref-type="ref"}. Together, these findings suggest that individuals with joint symptoms but without an OA/arthritis diagnosis represent a significant segment of the population.

Compared to those with neither an OA diagnosis nor joint symptoms, we found that older age, female sex, obesity, and a greater number of comorbid conditions were associated with a greater likelihood of having diagnosed OA and having possible OA. Other than comorbid conditions, these are known risk factors for OA [18](#acr211120-bib-0018){ref-type="ref"}, and the literature reports that individuals with OA are at an increased risk of having co‐occurring conditions, adjusting for age and sex [19](#acr211120-bib-0019){ref-type="ref"}, [20](#acr211120-bib-0020){ref-type="ref"}. The associations of sex, obesity, and co‐occurring conditions with having an OA diagnosis and having multiple symptomatic joints were strikingly similar and statistically indistinguishable. The only observed difference was the older age of those with a diagnosis. Although the same factors were also associated with an increased likelihood of reporting single joint symptoms, the magnitudes of associations were significantly lower compared with those for diagnosed OA.

Joint symptoms are associated with adverse consequences that include disability, poor self‐rated physical and mental health, and increased health service use, not unlike the case for OA specifically [11](#acr211120-bib-0011){ref-type="ref"}, [12](#acr211120-bib-0012){ref-type="ref"}, [13](#acr211120-bib-0013){ref-type="ref"}, [14](#acr211120-bib-0014){ref-type="ref"}, [15](#acr211120-bib-0015){ref-type="ref"}. Previous research has found that individuals with either diagnosed arthritis or joint symptoms generally are more likely to report difficulty with ADLs [11](#acr211120-bib-0011){ref-type="ref"}, [13](#acr211120-bib-0013){ref-type="ref"}. Our research builds on these findings in that, by distinguishing between those with single versus multiple joint symptoms, we identified similar likelihoods of reporting overall pain and difficulties with ADL between the diagnosed OA group and those reporting multiple symptoms, adjusted for the characteristics noted above. Considered together, our findings suggest the possibility that the multiple symptomatic joint group may represent an as‐of‐yet undiagnosed and younger cohort of individuals with OA. If this is the case, it means that in excess of half a million individuals with OA disease are being missed in Canada alone within the 45‐ to 85‐year age range when OA estimates are based exclusively on a doctor diagnosis. These numbers suggest that prudent health planning, policy making, and population‐level epidemiological work should consider this large group, which from a population burden and needs assessment perspective is often neglected. The widening of the "definition" of OA may raise initial concerns relating to the implications of overdiagnosis, for example. However, it must be considered that "overdiagnosis" in this case would apply to individuals who report having symptoms in multiple joints. Currently, OA treatment is targeted at symptom management; there are no disease‐modifying drugs. OA symptom management strategies, including self‐management and pharmacological treatment, are not dependent on a diagnosis. Whether these individuals are given an OA label or not, they have joint symptoms for which management strategies can be effective. Targeted messaging within this context to individuals with joint symptoms (diagnosis or not) seems advantageous from an individual and societal perspective.

Several limitations need to be considered when interpreting the findings of the study. Only the knee, hip, and hand joints were considered, both for the OA diagnosis and joint symptoms. Although these are the joint sites most frequently affected by OA [21](#acr211120-bib-0021){ref-type="ref"}, [22](#acr211120-bib-0022){ref-type="ref"}, the exclusion of other joint sites means that the prevalence of diagnosed OA and possible OA presented here are underestimates. As other joint sites were not considered, our "possible OA" and study referent group may have included individuals with OA and OA‐like symptoms, respectively. Although this would minimize discrimination between the groups, we nevertheless found gradients of association across groups, increasing from those with single joint symptoms to multijoint symptoms and OA diagnosis. As 94% of the sample identified as "white," ethnicity could not be assessed. The study was also cross‐sectional in design, limiting our ability to make causal inferences. Future work with longitudinal CLSA data will make it possible to examine what proportion of individuals with "possible OA" go on to report an OA diagnosis. Finally, data were self‐reported and are therefore subject to potential recall and reporting biases. However, self‐reported arthritis data have been found to be adequate for assessing burden in the population [23](#acr211120-bib-0023){ref-type="ref"}, [24](#acr211120-bib-0024){ref-type="ref"}.

Strengths of this study include the use of a large population‐based sample and the inclusion of data on diagnosed OA specifically, unlike the previously cited studies based on a general "arthritis" diagnosis, and inclusion of data on joint symptoms indicative of OA. Moreover, with respect to the latter, respondents were asked about specific joint symptoms, including activity, rather than on symptoms generally. This increased specificity may have captured joint symptoms that otherwise would have been missed or not recalled. Unlike previous work in this area, we made a distinction between individuals with single versus multijoint symptoms to gain further insight and specificity. Our study extends the work by Thomas et al [21](#acr211120-bib-0021){ref-type="ref"} in that the single‐ and multiple‐joint symptom groups, among those without a diagnosis (the group often not considered in health planning), were compared to those with a diagnosis (the group typically and exclusively considered in health planning). The similarity we report between the diagnosed group and those with multiple joint symptoms but without a diagnosis provides a basis for a reasonable argument that health and policy planners and epidemiological researchers should consider this latter group for population OA burden and needs assessments.

In summary, a quarter of the population had joint symptoms typical of OA but did not report an OA diagnosis. For those with multiple joint symptoms, representing one in four of this group, their characteristic profile and outcome profile were indistinguishable from those with an OA diagnosis, other than being younger. From a health and policy planning perspective, our results suggest that the dichotomy between doctor‐diagnosed disease versus not may be too restrictive and that an underlying continuum of amount of joint pain or number of joints with typical OA symptoms may be a more rational basis for policy and planning.
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